Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells

Mutation Research - DNA Repair

Volumn 461, Issue 3, 2000, Pages 221-228

  Arnaudeau, Catherine ^a   Miranda, Erika Tenorio ^b   Jenssen, Dag ^a   Helleday, Thomas ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cytostatic drugs; Hypoxanthine guanine phosphoribosyltransferase; Recombination; V79 Chinese hamster cell

Indexed keywords

CYTOSTATIC AGENT;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CHO CELL; DNA REPAIR; DNA SYNTHESIS; GENE MUTATION; GENETIC RECOMBINATION; GENETIC STABILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CRICETINAE; CRICETULUS; DNA REPLICATION; RECOMBINATION, GENETIC;

EID: 0034626885     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(00)00052-5     Document Type: Article

References (42)

1. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination
2. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice
3. Antioncogenes and human cancer
4. The role of mitotic recombination in carcinogenesis
5. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors
6. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein
7. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction
8. A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination
9. Effects of carcinogenic agents upon different mechanisms for intragenic recombination in mammalian cells
10. Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs
11. Mutagenic and carcinogenic properties of platinum-based anticancer drugs
12. International commission for protection against environmental mutagens and carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules
13. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo
14. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia
15. Hydroxyurea
16. Effect of methotrexate on murine bone marrow cells in vitro: Evidence of a reversible antiproliferative action
17. International commission for protection against environmental mutagens and carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents
18. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
19. Cytostatic, mutagenic, antineoplastic activities and preliminary toxicity of copper(II) new drugs; Casiopeinas I, II, III
20. Mechanistic and methodological aspects of chemically-induced somatic mutation and recombination in Drosophila melanogaster
21. Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis
22. Increased gene amplification in L5178Y mouse lymphoma cells with hydroxyurea-induced chromosomal aberrations
23. Induction, by thymidylate stress, of genetic recombination as evidenced by deletion of a transferred genetic marker in mouse FM3A cells
24. Inversion due to intrachromosomal recombination produced by carcinogens in a transgenic mouse model
25. Characterization of mutants involving partial exon duplications in the hprt gene of Chinese hamster V79 cells
26. The RAD51 protein supports homologous recombination by an exchange mechanism in mammalian cells
27. Chromosome breaks and genomic instability
28. Gene amplification in a single cell cycle in Chinese hamster ovary cells
29. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells
30. Site specificity of N-methyl-N-nitrosourea-induced transition mutations in the hprt gene
31. Toxicity and mutagenicity of 6 anti-cancer drugs in Chinese hamster V79 cells co-cultured with rat hepatocytes
32. Synergistic enhancement of the frequency of chromatid aberrations in cultured human lymphocytes by combinations of inhibitors of DNA repair
33. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: Comparison of DNA-reactive and non-DNA-reactive clastogens
34. Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites
35. Effects of inhibitors of DNA synthesis on spontaneous and ultraviolet light-induced sister-chromatid exchanges in Chinese hamster cells
36. Arsenic[III] and heavy metal salts induce intrachromosomal homologous recombination in the hprt gene in V79 Chinese hamster cells
37. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European study group on cytogenetic biomarkers and health (ESCH)
38. Cis-platinum(II) diamine dichloride causes mutation, transformation, and sister-chromatid exchanges in cultured mammalian cells
39. Molecular analysis of mutation at the hprt locus of Chinese hamster V79 cells induced by ethyl methanesulphonate and mitomycin C